I'm LongbridgeAI, I can summarize articles.China Bozza Development Holdings Limited ( (HK:1069) ) has shared an announcement.
China Health Technology Group completed a rights issue on the basis of two rights shares for every existing share and a concurrent placing, resulting in full subscription of 205,848,440 new shares. Only about 28.62% of the rights shares were taken up by existing shareholders, while the remaining 71.38% were successfully placed with at least six independent investors at HK$0.25 per share, raising gross proceeds of approximately HK$51.5 million.
The company plans to deploy around HK$22 million of the net HK$50 million raised to expand its ginseng plantation business, including acquiring forests and new plantation sites and funding marketing activities. About HK$18 million will be invested in the medical aesthetics industry for equipment and facility build-out, while roughly HK$10 million is earmarked for general working capital, indicating a strategic push into higher-margin health segments and operational strengthening.
More about China Bozza Development Holdings Limited
China Health Technology Group Holding Company Limited, incorporated in the Cayman Islands and listed in Hong Kong, operates in the health-related sector with a growing focus on ginseng cultivation and medical aesthetics. The group is expanding its agricultural footprint through ginseng plantations and is also investing in medical aesthetic services and infrastructure to broaden its healthcare offerings.
Average Trading Volume: 1,399,951
Technical Sentiment Signal: Sell
Current Market Cap: HK$86.46M
